• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自主功能性甲状腺结节患者中正常 TSH 值的患病率。

Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule.

机构信息

Department of Nuclear Medicine and Thyroid Center, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

Section of Endocrinology and Diabetology, Ospedale Israelitico, Rome, Italy.

出版信息

Eur J Clin Invest. 2015 Jul;45(7):739-44. doi: 10.1111/eci.12456. Epub 2015 Jun 1.

DOI:10.1111/eci.12456
PMID:25940693
Abstract

BACKGROUND

International guidelines significantly diverge on the effectiveness of thyroid scintigraphy (TS) in the initial work-up of thyroid nodules. In particular, the role of TS to detect or exclude the presence of autonomously functioning thyroid nodules (AFTN) in patients with normal serum thyrotropin (TSH) is still a matter to debate. Here, we aimed to review the literature on the prevalence of normal TSH value among patients with AFTN and meta-analyse data of the retrieved eligible papers.

MATERIALS AND METHODS

A comprehensive literature search of studies published from January 2000 to December 2014 on AFTN detected by TS was performed. Records reporting serum TSH values in AFTN were selected. Pooled prevalence of AFTN with normal TSH values was calculated on a per-patient analysis including 95% confidence intervals (95% CI).

RESULTS

Eight records including 2761 AFTN were selected for the meta-analysis. Pooled prevalence of AFTN with normal TSH detected by TS was 50% (95% CI: 32-68%). Selection bias in the included studies and heterogeneity among studies were potential limitations of the meta-analysis.

CONCLUSIONS

Present meta-analysis shows that about one in two patients with AFTN demonstrated by TS has a TSH value within normal references. As a consequence, TSH measurement may not be considered as effective as a single tool to detect or exclude AFTN, and TS remains mandatory.

摘要

背景

国际指南在甲状腺闪烁显像(TS)在甲状腺结节初始检查中的有效性方面存在显著差异。特别是,TS 检测或排除正常血清促甲状腺激素(TSH)患者中自主功能性甲状腺结节(AFTN)的作用仍然存在争议。在这里,我们旨在回顾有关 AFTN 患者中正常 TSH 值的患病率的文献,并对检索到的合格论文进行荟萃分析数据。

材料和方法

对 2000 年 1 月至 2014 年 12 月期间通过 TS 检测到的 AFTN 的研究进行了全面的文献检索。选择报告 AFTN 血清 TSH 值的记录。在包括 95%置信区间(95%CI)的每位患者分析中计算出 TSH 值正常的 AFTN 的汇总患病率。

结果

共选择了 8 份记录,包括 2761 例 AFTN 进行荟萃分析。TS 检测到的 TSH 值正常的 AFTN 的汇总患病率为 50%(95%CI:32-68%)。荟萃分析存在纳入研究的选择偏倚和研究间的异质性。

结论

目前的荟萃分析表明,大约每两名通过 TS 显示为 AFTN 的患者中就有一名患者的 TSH 值在正常参考范围内。因此,TSH 测量可能不能被认为是检测或排除 AFTN 的有效单一工具,并且 TS 仍然是强制性的。

相似文献

1
Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule.自主功能性甲状腺结节患者中正常 TSH 值的患病率。
Eur J Clin Invest. 2015 Jul;45(7):739-44. doi: 10.1111/eci.12456. Epub 2015 Jun 1.
2
Thyroid scintigraphy: an old tool is still the gold standard for an effective diagnosis of autonomously functioning thyroid nodules.甲状腺闪烁显像:一个古老的工具,仍然是有效诊断自主功能性甲状腺结节的金标准。
J Endocrinol Invest. 2013 Apr;36(4):233-6. doi: 10.3275/8471. Epub 2012 Jun 25.
3
TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients.促甲状腺激素(TSH)测定不适用于自主功能性甲状腺结节的筛查:一项对 368 例患者的回顾性研究。
Eur J Endocrinol. 2014 Mar 8;170(4):593-9. doi: 10.1530/EJE-13-1003. Print 2014 Apr.
4
Is TSH necessary for initial assessment of thyroid nodules?促甲状腺激素对于甲状腺结节的初始评估是否必要?
Clin Endocrinol (Oxf). 2017 Feb;86(2):263-269. doi: 10.1111/cen.13178. Epub 2016 Sep 22.
5
Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy.经皮乙醇注射治疗良性甲状腺病变:作用与疗效
Thyroid. 2004 Feb;14(2):125-31. doi: 10.1089/105072504322880364.
6
Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions.在碘缺乏地区寻找最有效的促甲状腺激素(TSH)阈值来排除自主功能性甲状腺结节。
Endocrine. 2016 Dec;54(3):757-761. doi: 10.1007/s12020-016-1094-3. Epub 2016 Sep 15.
7
LACK OF A THRESHOLD SIZE FOR AUTONOMOUSLY FUNCTIONING THYROID NODULES THAT EXCLUDES HYPERTHYROIDISM.自主功能性甲状腺结节并无明确大小标准可排除甲亢。
Endocr Pract. 2019 Dec;25(12):1263-1267. doi: 10.4158/EP-2019-0042. Epub 2019 Aug 14.
8
Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.自主功能性甲状腺结节的诊断与管理:沃尔特·里德陆军医疗中心的经验(1975 - 1996年)
Thyroid. 1998 Oct;8(10):871-80. doi: 10.1089/thy.1998.8.871.
9
Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.自主功能性甲状腺结节根据欧洲甲状腺影像报告和数据系统(EU-TIRADS)具有中等恶性风险,且细胞学检查结果为不确定。
Eur Thyroid J. 2023 Dec 20;12(6). doi: 10.1530/ETJ-23-0135. Print 2023 Dec 1.
10
[Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH].[放射性核素显像显示的“热”性甲状腺结节主要与促甲状腺激素正常并存]
Nuklearmedizin. 2011;50(5):179-88. doi: 10.3413/nukmed-0386-11-02. Epub 2011 Jul 8.

引用本文的文献

1
Pituitary-Thyroid Hormones and Related Indices in Euthyroid Type 2 Diabetes: Association With Thyroid Nodules.甲状腺功能正常的2型糖尿病患者的垂体-甲状腺激素及相关指标:与甲状腺结节的关联
Diabetes Metab Syndr Obes. 2025 Feb 27;18:627-636. doi: 10.2147/DMSO.S503444. eCollection 2025.
2
The European Association of Nuclear Medicine (EANM)'s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?欧洲核医学协会(EANM)对2023年欧洲甲状腺协会(ETA)甲状腺结节管理与核医学临床实践指南的回应:是有意疏忽吗?
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1678-1681. doi: 10.1007/s00259-023-06571-z.
3
Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results.
自主功能性甲状腺结节根据欧洲甲状腺影像报告和数据系统(EU-TIRADS)具有中等恶性风险,且细胞学检查结果为不确定。
Eur Thyroid J. 2023 Dec 20;12(6). doi: 10.1530/ETJ-23-0135. Print 2023 Dec 1.
4
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.2023 年欧洲甲状腺协会甲状腺结节管理临床实践指南。
Eur Thyroid J. 2023 Aug 14;12(5). doi: 10.1530/ETJ-23-0067. Print 2023 Oct 1.
5
2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation.2022年台湾甲状腺射频消融临床多中心专家共识与建议
Ultrasonography. 2023 Jul;42(3):357-375. doi: 10.14366/usg.22126. Epub 2022 Nov 19.
6
Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up.放射性碘治疗 1 级和 2 级亚临床甲状腺毒症:长达 18 年的随访结果。
Front Endocrinol (Lausanne). 2022 Mar 9;13:843857. doi: 10.3389/fendo.2022.843857. eCollection 2022.
7
Prevalence and Treatment Outcomes of Marine-Lenhart Syndrome in Japan.日本Marine-Lenhart综合征的患病率及治疗结果
Eur Thyroid J. 2021 Nov;10(6):461-467. doi: 10.1159/000510312. Epub 2020 Sep 30.
8
2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.2021年欧洲甲状腺协会关于碘对比剂所致甲状腺功能障碍管理的指南。
Eur Thyroid J. 2021 Jul;10(4):269-284. doi: 10.1159/000517175. Epub 2021 Jun 16.
9
Fusion iENA Scholar Study: Sensor-Navigated I-124-PET/US Fusion Imaging versus Conventional Diagnostics for Retrospective Functional Assessment of Thyroid Nodules by Medical Students.融合 iENA Scholar 研究:传感器导航 I-124-PET/US 融合成像与传统诊断在医学生回顾性甲状腺结节功能评估中的比较。
Sensors (Basel). 2020 Jun 17;20(12):3409. doi: 10.3390/s20123409.
10
Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS.根据美国甲状腺协会(ATA)2015版、欧洲甲状腺影像报告和数据系统(EU-TIRADS)以及美国放射学会(ACR)甲状腺影像报告和数据系统(ACR-TIRADS),在需要进行细针穿刺细胞学检查的人群中高功能甲状腺结节的患病率。
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1518-1526. doi: 10.1007/s00259-020-04740-y. Epub 2020 Mar 9.